XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses        
Research and development $ 10,106 $ 7,201 $ 17,516 $ 15,314
General and administrative 4,396 3,153 7,855 6,150
Total operating expenses 14,502 10,354 25,371 21,464
Loss from operations (14,502) (10,354) (25,371) (21,464)
Other income, net 869 775 1,443 1,113
Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds (31,274) (56,181) (44,610) (56,181)
Net loss and comprehensive loss $ (44,907) $ (65,760) $ (68,538) $ (76,532)
Net loss per share, Basic $ (1.06) $ (2.74) $ (1.9) $ (3.99)
Net loss per share, Diluted $ (1.06) $ (2.74) $ (1.9) $ (3.99)
Weighted-average common shares outstanding, Basic 42,278,411 24,006,549 36,133,906 19,173,080
Weighted Average Number of Shares Outstanding, Diluted 42,278,411 24,006,549 36,133,906 19,173,080